TRANSCEND CAPITAL ADVISORS, LLC – Gilead Sciences, Inc. Transaction History
TRANSCEND CAPITAL ADVISORS, LLC portfolio value:
$1.63M
portfolio value
TRANSCEND CAPITAL ADVISORS, LLC quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.96% | 510 shares | 28K | $61.69 | 26.52K |
| Q2 2022 | share | Increase | +0.34% | 88 shares | 67K | $61.81 | 26.01K |
| Q1 2022 | share | Increase | +47.06% | 8.29K shares | 261K | $59.45 | 25.92K |
| Q4 2021 | share | 0.00% | 0 shares | 86K | $73.36 | 17.62K | |
| Q3 2021 | share | Decrease | -0.72% | -128 shares | -30K | $69.85 | 17.62K |
| Q2 2021 | share | Decrease | -1.28% | -230 shares | 64K | $68.17 | 17.75K |
| Q1 2021 | share | Decrease | -11.17% | -2.26K shares | -20K | $63.33 | 17.98K |
| Q4 2020 | share | Decrease | -0.09% | -19 shares | -101K | $56.43 | 20.24K |
| Q3 2020 | share | Increase | +29.59% | 4.62K shares | 78K | $60.52 | 20.26K |
| Q2 2020 | share | Decrease | -20.18% | -3.95K shares | -263K | $72.94 | 15.63K |
| Q1 2020 | share | Increase | 0.00% | 19.59K shares | 1.46M | $70.22 | 19.59K |